Bayer Launches Clarinaze Allergy Control Following Successful Rx-to-OTC Switch In UK

Having received the green light for its prescription-to-OTC switch, Bayer is launching in UK pharmacies Clarinaze Allergy Control backed by a £1m marketing campaign.

Bayer
• Source: Shutterstock

Bayer is launching in UK pharmacies Clarinaze Allergy Control 0.05% Nasal Spray following the successful prescription-to-pharmacy-only switch of the product’s active ingredient mometasone furoate.

Indicated for use in adults to treat the symptoms of seasonal or perennial allergic rhinitis – such as sneezing, runny,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

More from Health